Organogenesis(ORGO)

15.01 0.11 0.7383%

今开:15.0昨收:14.9
最高:15.15 最低:14.7099
涨停价:0.0跌停价:0.0
总市值:1.924556173E9

Organogenesis的热门评论

7X24快讯05-27 22:29

ORGANOGENESIS(ORGO.O)涨超12%,该股将加入标普小盘600指数。查看全文

Organogenesis(ORGO)05-11 04:42

$Organogenesis(ORGO)$ 8-K Current report, items 1.01, 2.02, 5.02, and 9.01 Accession Number: 0001193125-21-156247 Act: 34 Size: 240 KB 网页链接查看全文

7X24快讯05-27 05:20

标普道琼斯指数公司:卡骆驰(CROX.O)将加入标普中盘400指数,ORGANOGENESIS(ORGO.O)将加入标普小盘600指数。查看全文

Organogenesis(ORGO)05-19 05:51

$Organogenesis(ORGO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-21-017917 Act: 34 Size: 250 KB 网页链接查看全文

Dreamland202003-22 22:53

$Organogenesis(ORGO)$ 一个月前在13块的时候就犹豫要不要买,觉得等跟着大盘回落再买比较好,结果等到了今天。买了一点看看后市如何表现吧查看全文

纳指去年涨幅创十年之最,2021年能否续写辉煌?

美股研究社01-06 17:57

本文作者:Sanghamitra Saha 2020年第四季度,乐观情绪席卷了整个市场,标普500指数和道琼斯指数在今年收盘时均创下新高。尽管COVID-19带来了挑战,但可观的收益发布、2021年经济复苏的希望、疫苗方面的积极进展以及超宽松的全球货币政策在2020年帮助了市场。 不过,科技股占主导地位的纳斯达克指...查看全文

Organogenesis(ORGO)2020-04-17 06:35

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-20-000004 Size: 10 KB 网页链接查看全文

Organogenesis(ORGO)2020-04-09 04:30

$Organogenesis(ORGO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-20-101356 Act: 34 Size: 39 KB 网页链接查看全文

Organogenesis(ORGO)07-21 12:33

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,卖出,160237普通股, $14.02查看全文

Organogenesis(ORGO)07-21 12:33

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,期权,160237普通股, $0.99查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Organogenesis的最新评论

Organogenesis(ORGO)2019-04-30 11:00

$Organogenesis(ORGO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-29 AccNo: 0000902664-19-002056 Size: 76 KB 网页链接查看全文

Organogenesis(ORGO)2019-04-02 10:55

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-04-01 AccNo: 0001193125-19-094515 Size: 14 KBItem 8.01: Other Events 网页链接查看全文

Organogenesis(ORGO)2019-03-21 00:30

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-03-20 AccNo: 0001193125-19-080044 Size: 19 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Organogenesis(ORGO)2019-03-19 23:25

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-03-19 AccNo: 0001193125-19-078641 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant...查看全文

Organogenesis(ORGO)2019-03-19 11:10

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-03-18 AccNo: 0001193125-19-078270 Size: 214 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Organogenesis(ORGO)2019-03-19 11:10

$Organogenesis(ORGO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-18 AccNo: 0001193125-19-078332 Size: 18 MB 网页链接查看全文

JohnnyBlo2019-03-19 04:35

$Organogenesis(ORGO)$ 起飞吧!查看全文

Organogenesis(ORGO)2019-03-15 10:25

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-03-14 AccNo: 0001193125-19-074833 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligati...查看全文

汇众医疗2019-03-13 11:31

【汇众医疗】3月12日医药股涨幅盘点:制药公司BPTH白血病的II期试验数据积极,上涨54.48% $Bio-Path Holdings(BPTH)$$Organogenesis(ORGO)$ $Agile Therapeutics(AGRX)$ 3月12日涨幅最大医药股分别是:制药公司Bio-Path Holdings上涨54.48%; 再生医学公司Organogenesis Holdings上涨37.70%;女性...查看全文

Organogenesis(ORGO)2019-03-13 00:05

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-03-12 AccNo: 0001193125-19-071061 Size: 17 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Organogenesis的公告

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,卖出,160237普通股, $14.02

$Organogenesis(ORGO)$ 内部交易: 2021-07-16,总裁 and CEO,Gillheeney Gary S. ,卖出,139763普通股, $14.74

$Organogenesis(ORGO)$ 内部交易: 2021-07-16,总裁 and CEO,Gillheeney Gary S. ,期权,139763普通股, $3.51

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,期权,160237普通股, $0.99

超过5%股东持股披露

$Organogenesis(ORGO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-21-001006 Act: 34 Size: 98 KB 网页链接

持股变动声明

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000060 Size: 8 KB 网页链接

$Organogenesis(ORGO)$ 内部交易: 2021-06-09,10% Owner,Albert Erani Family Trust date ,卖出,150000普通股, $15.31

$Organogenesis(ORGO)$ 内部交易: 2021-06-09,10% Owner,ERANI ALBERT ,卖出,150000普通股, $15.31

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000056 Size: 19 KB 网页链接

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000058 Size: 7 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21